{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:17:04Z","timestamp":1791897424241,"version":"4.3.4"},"reference-count":54,"publisher":"The Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,11,1]]},"DOI":"10.1210\/jc.2009-1097","type":"journal-article","created":{"date-parts":[[2009,10,6]],"date-time":"2009-10-06T23:33:35Z","timestamp":1254872015000},"page":"4216-4223","source":"Crossref","is-referenced-by-count":161,"title":["ACTH Deficiency, Higher Doses of Hydrocortisone Replacement, and Radiotherapy Are Independent Predictors of Mortality in Patients with Acromegaly"],"prefix":"10.1210","volume":"94","author":[{"given":"M.","family":"Sherlock","sequence":"first","affiliation":[{"name":"Centre for Endocrinology, Diabetes and Metabolism (M.S., A.A.A., J.A., M.C.S., P.M.S.), School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TH, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. C.","family":"Reulen","sequence":"additional","affiliation":[{"name":"Centre for Childhood Cancer Survivor Studies (R.C.R., M.M.H.), Department of Public Health and Epidemiology, University of Birmingham, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Aragon","family":"Alonso","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes and Metabolism (M.S., A.A.A., J.A., M.C.S., P.M.S.), School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TH, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ayuk","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes and Metabolism (M.S., A.A.A., J.A., M.C.S., P.M.S.), School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TH, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. N.","family":"Clayton","sequence":"additional","affiliation":[{"name":"Department of Postgraduate Medicine (R.N.C.), University of Keele, Hartshill, Stoke-on-Trent ST4 7QB, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Sheppard","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes and Metabolism (M.S., A.A.A., J.A., M.C.S., P.M.S.), School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TH, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M.","family":"Hawkins","sequence":"additional","affiliation":[{"name":"Centre for Childhood Cancer Survivor Studies (R.C.R., M.M.H.), Department of Public Health and Epidemiology, University of Birmingham, Birmingham B15 2TT, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S.","family":"Bates","sequence":"additional","affiliation":[{"name":"Birmingham Heartlands and Solihull National Health Service Trust (A.S.B.), Birmingham B9 5SS, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. M.","family":"Stewart","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes and Metabolism (M.S., A.A.A., J.A., M.C.S., P.M.S.), School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TH, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041114042364000_R1","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1210\/jc.2003-031584","article-title":"Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly.","volume":"89","author":"Ayuk","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042364000_R2","first-page":"293","article-title":"An audit of outcome of treatment in acromegaly.","volume":"86","author":"Bates","year":"1993","journal-title":"Q J Med"},{"key":"key\n\t\t\t\t2019041114042364000_R3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1365-2265.2003.01679.x","article-title":"Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly.","volume":"58","author":"Beauregard","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041114042364000_R4","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1210\/jc.2003-032041","article-title":"Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements.","volume":"89","author":"Biermasz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042364000_R5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2007-1191","article-title":"Mortality in acromegaly: a metaanalysis.","volume":"93","author":"Dekkers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042364000_R6","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/jc.2003-031199","article-title":"Factors influencing mortality in acromegaly.","volume":"89","author":"Holdaway","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042364000_R7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2265.1995.tb02913.x","article-title":"The Birmingham pituitary database: auditing the outcome of the treatment of acromegaly.","volume":"43","author":"Jenkins","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041114042364000_R8","first-page":"2730","article-title":"Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group.","volume":"83","author":"Orme","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042364000_R9","first-page":"1","article-title":"Mortality in acromegaly.","volume":"39","author":"Wright","year":"1970","journal-title":"Q J Med"},{"key":"key\n\t\t\t\t2019041114042364000_R10","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1210\/jc.2004-1381","article-title":"A nationwide survey of mortality in acromegaly.","volume":"90","author":"Kauppinen-Ma\u0308kelin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042364000_R11","first-page":"3419","article-title":"Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.","volume":"83","author":"Swearingen","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042364000_R12","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1210\/jc.2005-1616","article-title":"Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly.","volume":"91","author":"Jenkins","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042364000_R13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group.","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041114042364000_R14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","article-title":"Premature mortality due to cardiovascular disease in hypopituitarism.","volume":"336","author":"Rose\u0301n","year":"1990","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041114042364000_R15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jcem-72-1-39","article-title":"Daily cortisol production rate in man determined by stable isotope dilution\/mass spectrometry.","volume":"72","author":"Esteban","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042364000_R16","first-page":"1505","article-title":"Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis.","volume":"76","author":"Kerrigan","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042364000_R17","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2006-0524","article-title":"The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients.","volume":"91","author":"Filipsson","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042364000_R18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2265.1986.tb00755.x","article-title":"Does growth hormone releasing factor desensitize the somatotroph? Interpretation of responses of growth hormone during and after 10-hour infusion of GRF 1-29 amide in man.","volume":"24","author":"Davis","year":"1986","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041114042364000_R19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1055\/s-2007-1004898","article-title":"Variations in somatomedin-C\/insulin-like growth factor-I associated with environmental temperature and nutrition.","volume":"22","author":"Dauncey","year":"1990","journal-title":"Horm Metab Res"},{"key":"key\n\t\t\t\t2019041114042364000_R20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1365-2265.1998.00555.x","article-title":"Defining the normal cortisol response to the short Synacthen test: implications for the investigation of hypothalamic-pituitary disorders.","volume":"49","author":"Clark","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041114042364000_R21","year":"2005"},{"key":"key\n\t\t\t\t2019041114042364000_R22","first-page":"1","article-title":"Statistical methods in cancer research","author":"Breslow","year":"1987","journal-title":"Volume II. The design and analysis of cohort studies. IARC Scientific Publications no. 82, p"},{"key":"key\n\t\t\t\t2019041114042364000_R23","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1210\/jc.2004-1152","article-title":"Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years.","volume":"90","author":"Minniti","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042364000_R24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.clon.2004.01.012","article-title":"Evaluation of the effect of radiotherapy for pituitary tumours on cognitive function and quality of life.","volume":"16","author":"Noad","year":"2004","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"key\n\t\t\t\t2019041114042364000_R25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.tem.2005.09.008","article-title":"Pituitary radiotherapy: current controversies.","volume":"16","author":"Gittoes","year":"2005","journal-title":"Trends Endocrinol Metab"},{"issue":"Suppl 1","key":"key\n\t\t\t\t2019041114042364000_R26","first-page":"21","article-title":"Management of nonfunctioning pituitary adenomas","volume":"129","author":"Sassolas","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"key":"key\n\t\t\t\t2019041114042364000_R27","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1210\/jcem.85.10.6870","article-title":"Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center.","volume":"85","author":"Barrande","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042364000_R28","first-page":"145","article-title":"Hypopituitarism following external radiotherapy for pituitary tumours in adults.","volume":"70","author":"Littley","year":"1989","journal-title":"Q J Med"},{"key":"key\n\t\t\t\t2019041114042364000_R29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0360-3016(92)90941-A","article-title":"Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors.","volume":"30","author":"Tsang","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key\n\t\t\t\t2019041114042364000_R30","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0360-3016(99)00159-5","article-title":"The incidence of cerebrovascular accidents in patients with pituitary adenoma.","volume":"45","author":"Brada","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key\n\t\t\t\t2019041114042364000_R31","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1002\/1097-0142(19890615)63:12<2404::AID-CNCR2820631205>3.0.CO;2-3","article-title":"Incidence of cerebral infarction after radiotherapy for pituitary adenoma.","volume":"63","author":"Flickinger","year":"1989","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2019041114042364000_R32","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1365-2265.2002.01570.x","article-title":"Cerebrovascular mortality in patients with pituitary adenoma.","volume":"57","author":"Brada","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041114042364000_R33","first-page":"108","article-title":"Is the pathology of radiation injury different in small vs large blood vessels?","volume":"1","author":"Fajardo","year":"1999","journal-title":"Cardiovasc Radiat Med"},{"key":"key\n\t\t\t\t2019041114042364000_R34","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/cncr.2820690528","article-title":"Coronary artery disease mortality in patients treated for Hodgkin\u2019s disease.","volume":"69","author":"Boivin","year":"1992","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2019041114042364000_R35","first-page":"1169","article-title":"The effect of hypopituitarism on life expectancy.","volume":"81","author":"Bates","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042364000_R36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x","article-title":"Increased cerebrovascular mortality in patients with hypopituitarism.","volume":"46","author":"Bu\u0308low","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041114042364000_R37","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1210\/jc.2002-020526","article-title":"Risk factors for cerebrovascular deaths in patients operated and irradiated for pituitary tumors.","volume":"87","author":"Erfurth","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042364000_R38","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1210\/jc.2006-0076","article-title":"Premature mortality in patients with Addison\u2019s disease: a population-based study.","volume":"91","author":"Bergthorsdottir","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042364000_R39","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-2265.2008.03340.x","article-title":"Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency.","volume":"69","author":"Bensing","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041114042364000_R40","doi-asserted-by":"crossref","first-page":"764","DOI":"10.7326\/0003-4819-141-10-200411160-00007","article-title":"Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease.","volume":"141","author":"Wei","year":"2004","journal-title":"Ann Int Med"},{"key":"key\n\t\t\t\t2019041114042364000_R41","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/j.1552-4604.1991.tb01906.x","article-title":"Pharmacokinetics and oral bioavailability of hydrocortisone.","volume":"31","author":"Derendorf","year":"1991","journal-title":"J Clin Pharmacol"},{"key":"key\n\t\t\t\t2019041114042364000_R42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1677\/joe.0.1690065","article-title":"Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.","volume":"169","author":"Charmandari","year":"2001","journal-title":"J Endocrinol"},{"key":"key\n\t\t\t\t2019041114042364000_R43","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1210\/jcem.87.3.8297","article-title":"Cortisol and 17-hydroxyprogesterone kinetics in saliva after oral administration of hydrocortisone in children and young adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.","volume":"87","author":"Gro\u0308schl","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114042364000_R44","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1365-2265.1997.1340955.x","article-title":"An assessment of optimal hydrocortisone replacement therapy.","volume":"46","author":"Howlett","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041114042364000_R45","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1365-2265.1997.2101025.x","article-title":"Hydrocortisone replacement therapy in children and adolescents with hypopituitarism.","volume":"47","author":"DeVile","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041114042364000_R46","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2265.2005.02320.x","article-title":"Why is the management of glucocorticoid deficiency still controversial: a review of the literature.","volume":"63","author":"Crown","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041114042364000_R47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2265.2006.02544.x","article-title":"Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.","volume":"65","author":"Merza","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041114042364000_R48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/EJE-07-0052","article-title":"Continuous subcutaneous hydrocortisone infusion in Addison\u2019s disease.","volume":"157","author":"L\u00f8va\u030as","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041114042364000_R49","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1530\/EJE-08-0874","article-title":"Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy.","volume":"160","author":"Debono","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041114042364000_R50","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0022","article-title":"Systemic complications of acromegaly: epidemiology, pathogenesis, and management.","volume":"25","author":"Colao","year":"2004","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041114042364000_R51","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11102-005-1172-7","article-title":"Cardiovascular risk in Cushing\u2019s syndrome.","volume":"7","author":"Arnaldi","year":"2004","journal-title":"Pituitary"},{"key":"key\n\t\t\t\t2019041114042364000_R52","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","article-title":"Morbidity and mortality in Cushing\u2019s disease: an epidemiological approach.","volume":"40","author":"Etxabe","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041114042364000_R53","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1210\/er.2003-0031","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.","volume":"25","author":"Tomlinson","year":"2004","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041114042364000_R54","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2265.2007.02763.x","article-title":"Modulation of glucocorticoid metabolism by the growth hormone\u2013IGF-1 axis.","volume":"66","author":"Agha","year":"2007","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/94\/11\/4216\/9057805\/jcem4216.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T19:34:53Z","timestamp":1710617693000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/94\/11\/4216\/2596318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,1]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2009-1097","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1254957.8430059","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1254957.722055","asserted-by":"object"}]},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,1]]}}}